Amphastar Pharmaceuticals Inc
NASDAQ:AMPH
Amphastar Pharmaceuticals Inc
EPS (Diluted)
Amphastar Pharmaceuticals Inc
EPS (Diluted) Peer Comparison
Competitive EPS (Diluted) Analysis
Latest Figures & CAGR of Competitors
Company | EPS (Diluted) | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Amphastar Pharmaceuticals Inc
NASDAQ:AMPH
|
EPS (Diluted)
$2
|
CAGR 3-Years
343%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
25%
|
|
Johnson & Johnson
NYSE:JNJ
|
EPS (Diluted)
$15
|
CAGR 3-Years
41%
|
CAGR 5-Years
24%
|
CAGR 10-Years
12%
|
|
Bristol-Myers Squibb Co
NYSE:BMY
|
EPS (Diluted)
-$3
|
CAGR 3-Years
-3%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Pfizer Inc
NYSE:PFE
|
EPS (Diluted)
$0
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Merck & Co Inc
NYSE:MRK
|
EPS (Diluted)
$0
|
CAGR 3-Years
-31%
|
CAGR 5-Years
-23%
|
CAGR 10-Years
-5%
|
|
Eli Lilly and Co
NYSE:LLY
|
EPS (Diluted)
$6
|
CAGR 3-Years
0%
|
CAGR 5-Years
1%
|
CAGR 10-Years
7%
|
See Also
What is Amphastar Pharmaceuticals Inc's EPS (Diluted)?
EPS (Diluted)
2.6
USD
Based on the financial report for Dec 31, 2023, Amphastar Pharmaceuticals Inc's EPS (Diluted) amounts to 2.6 USD.
What is Amphastar Pharmaceuticals Inc's EPS (Diluted) growth rate?
EPS (Diluted) CAGR 10Y
25%
Over the last year, the EPS (Diluted) growth was 49%. The average annual EPS (Diluted) growth rates for Amphastar Pharmaceuticals Inc have been 343% over the past three years , and 25% over the past ten years .